Madrigal Pharmaceuticals, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/12/2026 | 2,771 | 0.0% | 4,759 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 2,114 | 0.0% | 4,609 | 9/30/2025 |
| 2025 Q2 | 8/13/2025 | 1,627 | 0.0% | 5,377 | 6/30/2025 |
| 2025 Q1 | 5/12/2025 | 1,569 | 0.0% | 4,737 | 3/31/2025 |
| 2024 Q4 | 2/10/2025 | 1,462 | 0.0% | 4,737 | 12/31/2024 |
| 2024 Q3 | 11/8/2024 | 1,075 | 0.0% | 5,067 | 9/30/2024 |
| 2024 Q2 | 8/8/2024 | 1,420 | 0.0% | 5,067 | 6/30/2024 |
| 2024 Q1 | 5/8/2024 | 867 | 0.0% | 3,577 | 3/31/2024 |
| 2023 Q4 | 2/9/2024 | 899 | 0.0% | 3,887 | 12/31/2023 |
| 2023 Q3 | 11/8/2023 | 568 | 0.0% | 3,887 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 893 | 0.0% | 3,867 | 6/30/2023 |
| 2023 Q1 | 6/14/2023 | 867 | 0.0% | 3,577 | 3/31/2023 |
| 2022 Q4 | 6/14/2023 | 1,323 | 0.0% | 4,557 | 12/31/2022 |
| 2022 Q3 | 11/8/2022 | 369 | 0.0% | 5,677 | 9/30/2022 |
| 2022 Q2 | 8/5/2022 | 517 | 0.0% | 7,227 | 6/30/2022 |
| 2022 Q1 | 5/6/2022 | 781 | 0.0% | 7,957 | 3/31/2022 |
| 2021 Q4 | 2/8/2022 | 674 | 0.0% | 7,957 | 12/31/2021 |
| 2021 Q3 | 11/8/2021 | 635 | 0.0% | 7,957 | 9/30/2021 |
| 2021 Q2 | 8/10/2021 | 746 | 0.0% | 7,657 | 6/30/2021 |
| 2021 Q1 | 5/10/2021 | 564 | 0.0% | 4,820 | 3/31/2021 |
| 2020 Q4 | 2/8/2021 | 583 | 0.0% | 5,240 | 12/31/2020 |
| 2020 Q3 | 11/9/2020 | 691 | 0.0% | 5,820 | 9/30/2020 |
| 2020 Q2 | 8/7/2020 | 548 | 0.0% | 4,840 | 6/30/2020 |
| 2020 Q1 | 5/5/2020 | 331 | 0.0% | 4,960 | 3/31/2020 |
| 2019 Q4 | 2/3/2020 | 452 | 0.0% | 4,960 | 12/31/2019 |